losclouds
Service profile

ImmunovantImmunovant

Biopharmaceutical company developing neonatal Fc receptor antagonist therapies for treating autoimmune diseases including thyroid eye disease, myasthenia gravis, and warm autoimmune hemolytic anemia

About

What Immunovant is

Biopharmaceutical company developing neonatal Fc receptor antagonist therapies for treating autoimmune diseases including thyroid eye disease, myasthenia gravis, and warm autoimmune hemolytic anemia

losclouds keeps public details for this profile. There are no catalog offerings to compare yet.

EnterpriseHealthcare

At a glance

Immunovant service facts
FactValue
Official sitehttps://immunovant.com
Status coveragePublic status page
Founded2018
HeadquartersNew York, New York, United States
CategoriesEnterprise, Healthcare
Loading offerings...